Concepedia

Jennifer D. Venable

JD

Statistics

Publications

11

Citations

631

H-Index

11

Active since

2003

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

Jennifer D. Venable is an author at Janssen (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2003–2023

11

Publications

11

The First Potent and Selective Non-Imidazole Human Histamine H<sub>4</sub>Receptor Antagonists

Jill A. Jablonowski, Cheryl A. Grice, Wenying Chai et al. · Journal of Medicinal Chemistry · 2003 · 196 citations · Full text

, , +14

Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation

Charles E. Hendrick, Jeff R. Jorgensen, Charu Chaudhry et al. · ACS Medicinal Chemistry Letters · 2022 · 156 citations · Full text

, , +14

Preparation and Biological Evaluation of Indole, Benzimidazole, and Thienopyrrole Piperazine Carboxamides:  Potent Human Histamine H<sub>4</sub>Antagonists

Jennifer D. Venable, Hui Cai, Wenying Chai et al. · Journal of Medicinal Chemistry · 2005 · 107 citations · Full text

, , +17

Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ–PI3Kδ Dual Inhibitors

Hong Peng Jia, Guangxiu Dai, Wei-guo Su et al. · Journal of Medicinal Chemistry · 2019 · 35 citations · Full text

, , +17

Discovery of Highly Potent and Selective IRAK1 Degraders to Probe Scaffolding Functions of IRAK1 in ABC DLBCL

Liqiang Fu, Jing Zhang, Bin Shen et al. · Journal of Medicinal Chemistry · 2021 · 25 citations · Full text

, , +13

1–5 of 11